Skip to main content
OpenTrials
Completed

NCT Number: NCT05248503

Impact of Complex Care Training of Hereditary Epidermolysis Bullosa on Caregiver Burden (FIREB)

Hereditary epidermolysis bullosa (EBH) is a rare, orphan disease characterized by skin and mucous membrane fragility.

The latest scientific data show that the proposed treatments are still in the experimental stage and that no curative treatment is available. The repercussions of this chronic disease, with neonatal onset, are major.

Epidermolysis bullosa requires multidisciplinary medical management, nursing care, psychological and social care.

Skin care involves preventing and treating chronic wounds and identifying their complications. The very great cutaneous-mucous fragility makes these treatments painful, long and complex, the caring hand itself being able to cause new wounds. Analgesics of different levels are not effective enough during treatment.

Along with counseling and education, nursing takes a central role in multi-professional accompaniment interventions to support and relieve families.

Parents became home caregivers out of necessity, and developed specific skills in epidermolysis bullosa, their child and dressings. They have great and demanding expectations of caregivers facing this rare disease, for which they are not trained in their degree course. Despite the severe nature of the disease, few studies have been carried out on the impact and psychosocial consequences on patients and their families, yet there is an expressed need for support.

The burden on parents is heavy, assessed by specific scales, but to date there are no studies examining the impact of epidermolysis bullosa care on caregiver stress.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Assistance Publique - Hôpitaux de Paris

Paris, 75015, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Nurse, nursing assistant, nursery nurse, childcare assistant, state graduates caring for patients with EBH and working at Necker Hospital.
  • Having participated in the entire training program specific to the complex care of epidermolysis bullosa.
  • Informed and not opposed to their participation in research.

Exclusion criteria

  • Person under tutorship or curatorship.
  • Other health professionals (physiotherapist, doctor, etc.).

Treatment and study plan

Complex Care Training of Hereditary Epidermolysis Bullosa

Behavioral

Training in the care of epidermolysis bullosa by combining theoretical content on the disease and practical workshops.

Primary outcomes

  1. Change of anxiety level

    Time frame: Change form baseline (before training) and at the end of the second day of training

    Anxiety will be assessed using the Anxiety - Spielberger State self-quiz, rated from 20 to 80 (80 indicating maximum anxiety state).

Secondary outcomes

  1. Anxiety evolution

    Time frame: 3 months after training

    Anxiety will be assessed using the Anxiety - Spielberger State self-quiz, rated from 20 to 80 (80 indicating maximum anxiety state).

  2. Anxiety auto-evaluation

    Time frame: Before training. 3 and 6 months after the training

    Self-assessment of factors that may induce anxiety measured on a Likert Scale from 0 to 4 (4 indicating a factors induces an high level of anxiety)

  3. Feeling of skills

    Time frame: Before training. 3 and 6 months after the training

    Self-assessment of feeling of skills on Likert scales from 0 to 4 (4 indicating a factors induces an high level of anxiety)

  4. Nurse knowledge about Epidermolysis bullosa

    Time frame: Before and after the training. 3 and 6 months after the training

    A true/false questionnaire with degree of certainty assessing knowledge about epidermolysis bullosa

  5. Satisfaction questionnaire

    Time frame: At the end of the second day of training.

    Satisfaction questionnaire on the quality and content of the training with a Likert scale ( 0 to 5; an higher score indicates better outcome) and open questions.

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • URC-CIC Paris Descartes Necker Cochin

Registry information

Acronym: FIREB

Important dates

Study start
2023
Primary completion
2023
Study completion
2025
First posted
Feb 21, 2022
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.